Rituximab significanly improves the outcome of Young poor risk patients with Diffuse Large B-Cell Lymphoma - on behalf of Czech Lymphoma Study Group | Charles Explorer

Rituximab significanly improves the outcome of Young poor risk patients with Diffuse Large B-Cell Lymphoma - on behalf of Czech Lymphoma Study Group

Publikace

Abstrakt

Diffuse large B-cell Lymphoma,poor risk,rituximab,Stem cell transplantation

Osoby